RA CAPITAL MANAGEMENT, L.P. - 23 Jun 2021 Form 3 Insider Report for Therapeutics Acquisition Corp.

Role: Director
Signature: /s/ Peter Kolchinsky, Manager of RA Capital Management, L.P.
Issuer symbol: N/A
Transactions as of: 23 Jun 2021
Net transactions value: $0
Form type: 3
Filing time: 24 Jun 2021, 19:02:39 UTC
Previous filing: 16 Jun 2021
Next filing: 30 Jun 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	PNT	Common Stock						889,218	23 Jun 2021	See footnote	F1, F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RA Capital Healthcare Fund, L.P. (the "Fund") acquired 889,218 shares of common stock of the issuer on 6/24/21 for a price of $10 per share.
F2	These securities are held directly by the Fund.
F3	RA Capital Management, L.P. (the "Adviser") is the investment manager for the Fund. The general partner of the Adviser is RA Capital Management GP, LLC (the "Adviser GP"), of which Dr. Peter Kolchinsky and Mr. Rajeev Shah are the managing members. The Adviser, the Adviser GP, Dr. Kolchinsky and Mr. Shah disclaim beneficial ownership of any of the reported securities, except to the extent of their pecuniary interest therein.

Remarks:

Dr. Kolchinsky, a managing member of the Adviser, is the Chief Executive Office and sits on the Board of Directors of the Issuer. Additionally, Matthew Hammond, a Principal of the Adviser, is the Chief Financial Officer and sits on the Board of Directors of the Issuer.